Addressing Rural Cancer Disparities via Proactive Smoking Cessation Treatment within Primary Care: A Hybrid Type 1 Effectiveness-Implementation Trial of a Scalable Smoking Cessation Electronic Visit

通过初级保健中的主动戒烟治疗解决农村癌症差异:可扩展戒烟电子就诊的 1 型混合有效性实施试验

基本信息

项目摘要

ABSTRACT Rural residents are both more likely to smoke cigarettes and less likely to quit than their urban counterparts. Consequently, individuals in rural areas have a 7% higher incidence of tobacco-associated cancers. Comprehensive smoking cessation treatment dissemination strategies are needed to increase utilization of evidence-based treatment, improve cessation outcomes, and ultimately decrease cancer incidence among rural smokers. Primary care providers (PCPs) see 70% of smokers annually, and rural residents are more likely than urban residents to have a usual source of health care. As such, primary care offers a ripe opportunity to deliver cessation treatment to rural smokers. All primary care practices that qualify for Centers for Medicare and Medicaid Services reimbursement are required to maintain electronic health records (EHRs) with coded smoking status data for adult patients. These data can be utilized to proactively identify smokers and deliver remote treatment. Our team recently completed a pilot study to develop, refine, and preliminarily evaluate a proactive asynchronous smoking cessation electronic visit (e-visit) delivered via the EHR. The goal of the e-visit is to automate best practice guidelines for cessation treatment via primary care to ensure that all smokers receive an evidence-based intervention. An initial baseline e-visit gathers information about smoking history and motivation to quit, followed by an algorithm to determine the best FDA-approved cessation medication to prescribe. A one- month follow-up e-visit assesses progress toward cessation. Clinical outcomes of our pilot (N=51 followed for three months) were promising. Among rural participants who received the e-visit (n=6), 17% reported 7-day point prevalence abstinence (PPA), 67% reduced their cigarettes per day (CPD) by >50%, and 50% used a cessation medication. E-visit participants, relative to treatment as usual (TAU), were 4.2 times more likely to report 7-day PPA, 4.1 times more likely to have reduced their CPD by >50%, and 4.7 times more likely to have used a cessation medication. Acceptability outcomes were strong, with 100% of rural e-visit participants reporting that they would use an e-visit again in the future. These data suggest that the e-visit may be a feasible, efficacious approach to extend the reach of evidence-based cessation treatment via rural primary care. We now propose a Hybrid Type I effectiveness-implementation trial to comprehensively assess e-visit effectiveness relative to TAU while simultaneously evaluating implementation when delivered across rural primary care settings. Effectiveness outcomes will be assessed through 6-months of follow-up and include: 1) biochemically verified 7-day PPA, 2) reduction in CPD, and 3) evidence-based cessation treatment utilization. Implementation outcomes will be assessed at patient, provider, and organizational levels. This trial has the potential to expand cessation treatment access in a manner scalable across rural healthcare systems and ultimately reduce rural cancer disparities.
摘要 与城市居民相比,农村居民吸烟的可能性更大,戒烟的可能性更小。 因此,农村地区的个人患烟草相关癌症的发病率高出7%。 需要全面的戒烟治疗传播策略,以增加 循证治疗,改善戒烟结果,并最终降低农村癌症发病率 吸烟者。初级保健提供者(PCP)每年看到70%的吸烟者,农村居民更有可能比 城市居民有正常的医疗来源。因此,初级保健提供了一个提供 对农村吸烟者进行戒烟治疗。所有符合医疗保险中心资格的初级保健实践, 需要医疗补助服务报销来维护带有吸烟编码的电子健康记录(EHR) 成人患者的状态数据。这些数据可用于主动识别吸烟者并提供远程 治疗我们的团队最近完成了一项试点研究,以开发,完善和初步评估一个积极的 通过EHR提供的异步戒烟电子访视(e访视)。电子访问的目标是 通过初级保健实现戒烟治疗最佳实践指南的自动化,以确保所有吸烟者都能获得 循证干预。最初的基线电子访问收集有关吸烟史和动机的信息 戒烟,其次是一个算法,以确定最好的FDA批准的戒烟药物处方。一个- 一个月随访电子访视评估戒烟进展。我们的试点的临床结果(N=51, 三个月)是有希望的。在接受电子访视的农村参与者(n=6)中,17%报告了7天的时间点 戒烟率(PPA),67%的人每天减少吸烟量(CPD)> 50%,50%的人戒烟 药相对于常规治疗(TAU),电子访视受试者报告7天 PPA,4.1倍更有可能减少他们的CPD> 50%,4.7倍更有可能使用 停止用药。可接受性结果很强,100%的农村电子访问参与者报告说, 他们将来会再次使用电子访问。这些数据表明,电子访视可能是一种可行的,有效的 通过农村初级保健扩大循证戒烟治疗的覆盖面。我们现在提出一个 混合I型有效性-实施试验,以全面评估电子访视相对于TAU的有效性 同时评估在农村初级保健机构提供服务的执行情况。有效性 将通过6个月的随访评估结果,包括:1)经过生化验证的7天PPA,2) 减少CPD,3)循证戒烟治疗的利用。执行成果将是 在患者、提供者和组织层面进行评估。这项试验有可能扩大戒烟治疗 以可扩展的方式在农村医疗保健系统中提供服务,并最终减少农村癌症差异。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jennifer Renee Dahne其他文献

Jennifer Renee Dahne的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jennifer Renee Dahne', 18)}}的其他基金

Hybrid Type 1 Effectiveness-Implementation Trial of a Proactive Smoking Cessation Electronic Visit for Scalable Delivery via Primary Care
主动戒烟电子就诊的混合 1 型有效性实施试验,通过初级保健进行可扩展交付
  • 批准号:
    10365698
  • 财政年份:
    2022
  • 资助金额:
    $ 96.54万
  • 项目类别:
Addressing Rural Cancer Disparities via Proactive Smoking Cessation Treatment within Primary Care: A Hybrid Type 1 Effectiveness-Implementation Trial of a Scalable Smoking Cessation Electronic Visit
通过初级保健中的主动戒烟治疗解决农村癌症差异:可扩展戒烟电子就诊的 1 型混合有效性实施试验
  • 批准号:
    10701074
  • 财政年份:
    2022
  • 资助金额:
    $ 96.54万
  • 项目类别:
Hybrid Type 1 Effectiveness-Implementation Trial of a Proactive Smoking Cessation Electronic Visit for Scalable Delivery via Primary Care
主动戒烟电子就诊的混合 1 型有效性实施试验,通过初级保健进行可扩展交付
  • 批准号:
    10552585
  • 财政年份:
    2022
  • 资助金额:
    $ 96.54万
  • 项目类别:
Development and Evaluation of a Brief Behavioral Activation Mobile Application for Nicotine Vaping Cessation Among Adolescent Primary Care Patients
针对青少年初级保健患者戒烟尼古丁的简短行为激活移动应用程序的开发和评估
  • 批准号:
    10250714
  • 财政年份:
    2021
  • 资助金额:
    $ 96.54万
  • 项目类别:
Remote Methods to Biochemically Verify Smoking Status
生化验证吸烟状况的远程方法
  • 批准号:
    9884111
  • 财政年份:
    2020
  • 资助金额:
    $ 96.54万
  • 项目类别:
Development and Testing of a Depression-Specific Behavioral Activation Mobile App Paired with Nicotine Replacement Therapy Sampling for Smoking Cessation Treatment Via Primary Care
开发和测试抑郁症特异性行为激活移动应用程序,并结合尼古丁替代疗法采样,通过初级保健进行戒烟治疗
  • 批准号:
    10364683
  • 财政年份:
    2018
  • 资助金额:
    $ 96.54万
  • 项目类别:
Development and Testing of a Depression-Specific Behavioral Activation Mobile App Paired with Nicotine Replacement Therapy Sampling for Smoking Cessation Treatment Via Primary Care
开发和测试抑郁症特异性行为激活移动应用程序,并结合尼古丁替代疗法采样,通过初级保健进行戒烟治疗
  • 批准号:
    10112873
  • 财政年份:
    2018
  • 资助金额:
    $ 96.54万
  • 项目类别:
Development and testing of a behavioral activation mobile therapy for elevated depressive symptoms
针对抑郁症状加重的行为激活移动疗法的开发和测试
  • 批准号:
    10341195
  • 财政年份:
    2015
  • 资助金额:
    $ 96.54万
  • 项目类别:
Development and testing of a behavioral activation mobile therapy for elevated depressive symptoms
针对抑郁症状加重的行为激活移动疗法的开发和测试
  • 批准号:
    10006356
  • 财政年份:
    2015
  • 资助金额:
    $ 96.54万
  • 项目类别:
Development and testing of a behavioral activation mobile therapy for elevated depressive symptoms
针对抑郁症状加重的行为激活移动疗法的开发和测试
  • 批准号:
    10116480
  • 财政年份:
    2015
  • 资助金额:
    $ 96.54万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 96.54万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 96.54万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 96.54万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 96.54万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 96.54万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 96.54万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 96.54万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 96.54万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 96.54万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 96.54万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了